Literature DB >> 10508249

Peptide dependency and selectivity of the NK cell inhibitory receptor Ly-49C.

L Franksson1, J Sundbäck, A Achour, J Bernlind, R Glas, K Kärre.   

Abstract

MHC class I molecules can prevent NK cell-mediated cytotoxicity by interacting with inhibitory receptors on the effector cells. Different conclusions have been reached regarding possible peptide selectivity of these receptors. To address whether peptide selectivity is an exclusive feature of human or immunoglobulin-superfamily receptors, we have studied a system based on the murine NK receptor Ly-49C in the lectin-superfamily. Loading of TAP-deficient RMA-S cells with the H-2Kb-restricted, ovalbumin-derived peptide OVA(257 - 264) (pOVA) induced their ability to bind Ly-49C-transfected reporter cells, and also protected them from killing by Ly-49C+ NK cells. Other peptides that bound and stabilized H-2Kb equally well differed in their NK protective capacity. Comparison of the MHC class I peptide complexes (crystal structures and molecular models) revealed a conformational motif encompassing the C-terminal parts of the alpha1 helix (73 - 77) and the bound peptide that was common for the protective complexes. Substitution analysis of pOVA suggested that position 7 in the peptide may be critical for optimal protection as well as for the conformational motif at position 73 - 77. In conclusion, protection mediated by the murine C-type lectin receptor Ly-49C is peptide dependent and selective.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508249     DOI: 10.1002/(SICI)1521-4141(199909)29:09<2748::AID-IMMU2748>3.0.CO;2-C

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

Review 1.  Structure of the Ly49 family of natural killer (NK) cell receptors and their interaction with MHC class I molecules.

Authors:  Nazzareno Dimasi; Lorenzo Moretta; Roberto Biassoni
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 2.  Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors.

Authors:  Lu Deng; Roy A Mariuzza
Journal:  Semin Immunol       Date:  2006-06       Impact factor: 11.130

Review 3.  Cis interactions of immunoreceptors with MHC and non-MHC ligands.

Authors:  Werner Held; Roy A Mariuzza
Journal:  Nat Rev Immunol       Date:  2008-02-29       Impact factor: 53.106

4.  The activating Ly49W and inhibitory Ly49G NK cell receptors display similar affinities for identical MHC class I ligands.

Authors:  Brian J Ma; Carla M Craveiro Salvado; Kevin P Kane
Journal:  Immunogenetics       Date:  2014-05-07       Impact factor: 2.846

5.  Recognition of class I MHC by a rat Ly49 NK cell receptor is dependent on the identity of the P2 anchor amino acid of bound peptide.

Authors:  Brian J Ma; Kevin P Kane
Journal:  J Immunol       Date:  2011-08-12       Impact factor: 5.422

6.  Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection.

Authors:  Marie-Pierre Desrosiers; Agnieszka Kielczewska; J-C Loredo-Osti; Sonia Girard Adam; Andrew P Makrigiannis; Suzanne Lemieux; Trung Pham; Melissa B Lodoen; Kenneth Morgan; Lewis L Lanier; Silvia M Vidal
Journal:  Nat Genet       Date:  2005-05-15       Impact factor: 38.330

7.  Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands.

Authors:  Taewoong Choi; Stephen T Ferris; Naoki Matsumoto; Jennifer Poursine-Laurent; Wayne M Yokoyama
Journal:  J Immunol       Date:  2011-02-18       Impact factor: 5.422

8.  Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect.

Authors:  Daniel R Brims; Jie Qian; Irene Jarchum; Leann Mikesh; Edith Palmieri; Udupi A Ramagopal; Vladimir N Malashkevich; Rodolfo J Chaparro; Torben Lund; Masakazu Hattori; Jeffrey Shabanowitz; Donald F Hunt; Stanley G Nathenson; Steven C Almo; Teresa P Dilorenzo
Journal:  Int Immunol       Date:  2010-01-21       Impact factor: 4.823

9.  Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes.

Authors:  J R Kraft; R E Vance; J Pohl; A M Martin; D H Raulet; P E Jensen
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

10.  A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.

Authors:  Jakob Michaëlsson; Cristina Teixeira de Matos; Adnane Achour; Lewis L Lanier; Klas Kärre; Kalle Söderström
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.